Explore how Emulate and ZEISS are advancing drug development using organ-chip technology and AI for enhanced imaging. This joint webinar discusses overcoming the limitations of traditional models to improve clinical outcomes.
Revolutionizing Drug Development with NAMs and AI Workflows
Key Takeaways
- Research focus: NAMs and AI workflows for drug development.
- Model system: Human organ-chip technology.
- Research goal: Reduce clinical trial failures and costs.
- Presented by: Experts from Emulate and ZEISS.
- Content type: Educational Webinar with Q&A session.
Play
Enabling Drug Development with NAMs: Scalable Imaging and AI Analysis Workflows for Organ-Chip
Related To Drug Discovery and Screening
Content For BioTech / Pharma Scientists
Content For Human Tissue Studies
Similar to Enabling Drug Development with NAMs: Scalable Imaging and AI Analysis Workflows for Organ-Chip
Newest Content
Powered by Navless.ai